ImmunityBio Inc. (IBRX) attracts a new wave of investors despite economic turmoil

ImmunityBio Inc. (NASDAQ: IBRX) closed the day trading at $5.16 down -2.09% from the previous closing price of $5.27. In other words, the price has decreased by -$0.11 from its previous closing price. On the day, 1037338 shares were traded. IBRX stock price reached its highest trading level at $5.21 during the session, while it also had its lowest trading level at $5.04.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report



For a better understanding of IBRX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.00 and its Current Ratio is at 2.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on August 03, 2022, initiated with a Buy rating and assigned the stock a target price of $8.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 3658.18.

Stock Price History:

Over the past 52 weeks, IBRX has reached a high of $8.01, while it has fallen to a 52-week low of $2.60. The 50-Day Moving Average of the stock is 5.33, while the 200-Day Moving Average is calculated to be 4.84.

Shares Statistics:

Over the past 3-months, IBRX traded about 1.72M shares per day on average, while over the past 10 days, IBRX traded about 1.65M shares per day. A total of 400.06M shares are outstanding, with a floating share count of 83.44M. Insiders hold about 79.16% of the company’s shares, while institutions hold 10.30% stake in the company. Shares short for IBRX as of Oct 13, 2022 were 23.49M with a Short Ratio of 23.73M, compared to 21.77M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 5.87% and a Short% of Float of 28.12%.

Earnings Estimates

Current recommendations for the stock of the company come from 2 analysts. On average, analysts expect EPS of -$0.23 for the current quarter, with a high estimate of -$0.2 and a low estimate of -$0.26, while EPS last year was -$0.22. The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.11 and low estimates of -$0.19.

Analysts are recommending an EPS of between -$0.85 and -$0.88 for the fiscal current year, implying an average EPS of -$0.86. EPS for the following year is -$0.87, with 2 analysts recommending between -$0.85 and -$0.89.

Revenue Estimates

A total of 2 analysts have provided revenue estimates for IBRX’s current fiscal year. The highest revenue estimate was $400k, while the lowest revenue estimate was $100k, resulting in an average revenue estimate of $250k. In the same quarter a year ago, actual revenue was $934k, down -73.20% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $11.4M in the next fiscal year. The high estimate is $20.21M and the low estimate is $2.6M. The average revenue growth estimate for next year is up 4,460.00% from the average revenue estimate for this year.